Cabaletta Bio Net Income
| CABA Stock | USD 2.51 0.08 3.09% |
As of the 6th of February, Cabaletta Bio shows the risk adjusted performance of 0.0377, and Mean Deviation of 4.82. Cabaletta Bio technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Cabaletta Bio's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Cabaletta Bio's valuation are provided below:We have found one hundred twenty available fundamental signals for Cabaletta Bio, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Cabaletta Bio prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. | Last Reported | Projected for Next Year | ||
| Net Loss | -104.3 M | -99.1 M | |
| Net Loss | -47.7 M | -45.3 M | |
| Net Loss | -104.3 M | -99.1 M | |
| Net Loss | (2.69) | (2.83) |
Cabaletta | Net Income | Build AI portfolio with Cabaletta Stock |
Analyzing Cabaletta Bio's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Cabaletta Bio's current valuation and future prospects.
Latest Cabaletta Bio's Net Income Growth Pattern
Below is the plot of the Net Income of Cabaletta Bio over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Cabaletta Bio financial statement analysis. It represents the amount of money remaining after all of Cabaletta Bio operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Cabaletta Bio's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cabaletta Bio's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (115.86 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Cabaletta Net Income Regression Statistics
| Arithmetic Mean | (32,118,548) | |
| Coefficient Of Variation | (128.71) | |
| Mean Deviation | 34,339,351 | |
| Median | (12,202,000) | |
| Standard Deviation | 41,340,936 | |
| Sample Variance | 1709.1T | |
| Range | 115.6M | |
| R-Value | (0.89) | |
| Mean Square Error | 380.8T | |
| R-Squared | 0.79 | |
| Slope | (7,281,698) | |
| Total Sum of Squares | 27345.2T |
Cabaletta Net Income History
Other Fundumenentals of Cabaletta Bio
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Cabaletta Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Cabaletta Bio is extremely important. It helps to project a fair market value of Cabaletta Stock properly, considering its historical fundamentals such as Net Income. Since Cabaletta Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cabaletta Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cabaletta Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. Projected growth potential of Cabaletta fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Cabaletta Bio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Cabaletta Bio's market price often diverges from its book value, the accounting figure shown on Cabaletta's balance sheet. Smart investors calculate Cabaletta Bio's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Cabaletta Bio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Cabaletta Bio's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cabaletta Bio should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cabaletta Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cabaletta Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cabaletta Bio.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in Cabaletta Bio on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding Cabaletta Bio or generate 0.0% return on investment in Cabaletta Bio over 90 days. Cabaletta Bio is related to or competes with GeoVax Labs, BioLineRx, Tharimmune, Ainos, OSR Holdings, Lipocine, and SeaStar Medical. Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T ce... More
Cabaletta Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cabaletta Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cabaletta Bio upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.29 | |||
| Information Ratio | 0.0325 | |||
| Maximum Drawdown | 62.77 | |||
| Value At Risk | (7.27) | |||
| Potential Upside | 8.44 |
Cabaletta Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cabaletta Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cabaletta Bio's standard deviation. In reality, there are many statistical measures that can use Cabaletta Bio historical prices to predict the future Cabaletta Bio's volatility.| Risk Adjusted Performance | 0.0377 | |||
| Jensen Alpha | 0.3195 | |||
| Total Risk Alpha | (0.08) | |||
| Sortino Ratio | 0.05 | |||
| Treynor Ratio | (0.54) |
Cabaletta Bio February 6, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0377 | |||
| Market Risk Adjusted Performance | (0.53) | |||
| Mean Deviation | 4.82 | |||
| Semi Deviation | 4.85 | |||
| Downside Deviation | 5.29 | |||
| Coefficient Of Variation | 2627.15 | |||
| Standard Deviation | 8.14 | |||
| Variance | 66.26 | |||
| Information Ratio | 0.0325 | |||
| Jensen Alpha | 0.3195 | |||
| Total Risk Alpha | (0.08) | |||
| Sortino Ratio | 0.05 | |||
| Treynor Ratio | (0.54) | |||
| Maximum Drawdown | 62.77 | |||
| Value At Risk | (7.27) | |||
| Potential Upside | 8.44 | |||
| Downside Variance | 28.03 | |||
| Semi Variance | 23.51 | |||
| Expected Short fall | (6.67) | |||
| Skewness | 3.13 | |||
| Kurtosis | 15.98 |
Cabaletta Bio Backtested Returns
At this point, Cabaletta Bio is unstable. Cabaletta Bio secures Sharpe Ratio (or Efficiency) of 0.0351, which signifies that the company had a 0.0351 % return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Cabaletta Bio, which you can use to evaluate the volatility of the firm. Please confirm Cabaletta Bio's risk adjusted performance of 0.0377, and Mean Deviation of 4.82 to double-check if the risk estimate we provide is consistent with the expected return of 0.19%. Cabaletta Bio has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.56, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Cabaletta Bio are expected to decrease at a much lower rate. During the bear market, Cabaletta Bio is likely to outperform the market. Cabaletta Bio right now shows a risk of 5.42%. Please confirm Cabaletta Bio mean deviation, standard deviation, treynor ratio, as well as the relationship between the downside deviation and total risk alpha , to decide if Cabaletta Bio will be following its price patterns.
Auto-correlation | 0.27 |
Poor predictability
Cabaletta Bio has poor predictability. Overlapping area represents the amount of predictability between Cabaletta Bio time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cabaletta Bio price movement. The serial correlation of 0.27 indicates that nearly 27.0% of current Cabaletta Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.27 | |
| Spearman Rank Test | -0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.1 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Cabaletta Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Cabaletta Bio reported net income of (115.86 Million). This is 133.95% lower than that of the Biotechnology sector and 265.41% lower than that of the Health Care industry. The net income for all United States stocks is 120.29% higher than that of the company.
Cabaletta Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cabaletta Bio's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cabaletta Bio could also be used in its relative valuation, which is a method of valuing Cabaletta Bio by comparing valuation metrics of similar companies.Cabaletta Bio is currently under evaluation in net income category among its peers.
Cabaletta Bio ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Cabaletta Bio's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Cabaletta Bio's managers, analysts, and investors.Environmental | Governance | Social |
Cabaletta Bio Institutional Holders
Institutional Holdings refers to the ownership stake in Cabaletta Bio that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Cabaletta Bio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Cabaletta Bio's value.| Shares | Anson Funds Management Lp | 2025-06-30 | 1.8 M | Citadel Advisors Llc | 2025-06-30 | 1.7 M | Schonfeld Strategic Advisors Llc | 2025-06-30 | 1.5 M | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 1.3 M | Woodline Partners Lp | 2025-06-30 | 1.2 M | Blue Owl Capital Holdings Lp | 2025-06-30 | 1.1 M | Superstring Capital Management Lp | 2025-06-30 | 1.1 M | Blackrock Inc | 2025-06-30 | 970.6 K | Millennium Management Llc | 2025-06-30 | 855.3 K | Bain Capital Life Sciences Investors, Llc | 2025-06-30 | 9.7 M | Adage Capital Partners Gp Llc | 2025-06-30 | 8.8 M |
Cabaletta Fundamentals
| Return On Equity | -1.01 | ||||
| Return On Asset | -0.52 | ||||
| Current Valuation | 106.51 M | ||||
| Shares Outstanding | 96.27 M | ||||
| Shares Owned By Insiders | 1.57 % | ||||
| Shares Owned By Institutions | 75.05 % | ||||
| Number Of Shares Shorted | 18.44 M | ||||
| Price To Earning | (3.33) X | ||||
| Price To Book | 1.73 X | ||||
| EBITDA | (110.3 M) | ||||
| Net Income | (115.86 M) | ||||
| Cash And Equivalents | 96.81 M | ||||
| Cash Per Share | 3.34 X | ||||
| Total Debt | 15.6 M | ||||
| Debt To Equity | (3.76) % | ||||
| Current Ratio | 15.22 X | ||||
| Book Value Per Share | 1.45 X | ||||
| Cash Flow From Operations | (88.22 M) | ||||
| Short Ratio | 10.43 X | ||||
| Earnings Per Share | (2.32) X | ||||
| Target Price | 13.13 | ||||
| Number Of Employees | 148 | ||||
| Beta | 3.3 | ||||
| Market Capitalization | 241.63 M | ||||
| Total Asset | 185.05 M | ||||
| Retained Earnings | (349.1 M) | ||||
| Working Capital | 139.59 M | ||||
| Current Asset | 30.42 M | ||||
| Current Liabilities | 843.74 K | ||||
| Net Asset | 185.05 M |
About Cabaletta Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cabaletta Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cabaletta Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cabaletta Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cabaletta Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cabaletta Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cabaletta Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cabaletta Bio Stock:Check out For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. Projected growth potential of Cabaletta fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Cabaletta Bio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Cabaletta Bio's market price often diverges from its book value, the accounting figure shown on Cabaletta's balance sheet. Smart investors calculate Cabaletta Bio's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Cabaletta Bio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Cabaletta Bio's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cabaletta Bio should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.